Unknown

Dataset Information

0

Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR.


ABSTRACT: In March 2020, WHO declared a pandemic state due to SARS-CoV-2 having spread. TaqMan-based real-time RT-qPCR is currently the gold standard for COVID-19 diagnosis. However, it is a high-cost assay, inaccessible for the majority of laboratories around the world, making it difficult to diagnose on a large scale. The objective of this study was to standardize lower cost molecular methods for SARS-CoV-2 identification. E gene primers previously determined for TaqMan assays by Colman et al. (2020) were adapted in SYBR Green assay and RT-PCR conventional. The cross-reactivity test was performed with 17 positive samples for other respiratory viruses, and the sensibility test was performed with 8 dilutions (10 based) of SARS-CoV-2 isolated and 63 SARS-CoV-2-positive samples. The SYBR Green assays and conventional RT-PCR have not shown amplification of the 17 respiratory samples positives for other viruses. The SYBR Green-based assay was able to detect all 8 dilutions of the isolate. The conventional PCR detected until 107 dilution, both assays detected the majority of the 63 samples, 98.42% of positivity in SYBR Green, and 93% in conventional PCR. The average Ct variation between SYBR Green and TaqMan was 1.92 and the highest Ct detected by conventional PCR was 35.98. Both of the proposed assays are less sensitive than the current gold standard; however, our data shows a low sensibility variation, suggesting that these methods could be used by laboratories as a lower cost molecular method for SARS-CoV-2 diagnosis.

SUBMITTER: Dorlass EG 

PROVIDER: S-EPMC7411266 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR.

Dorlass Erick Gustavo EG   Monteiro Cairo Oliveira CO   Viana Amanda Oliveira AO   Soares Camila Pereira CP   Machado Rafael Rahal Guaragna RRG   Thomazelli Luciano Matsumiya LM   Araujo Danielle Bastos DB   Leal Fabyano Bruno FB   Candido Erika Donizette ED   Telezynski Bruna Larotonda BL   Valério Camila Araujo CA   Chalup Vanessa Nascimento VN   Mello Ralyria R   Almeida Flavia Jaqueline FJ   Aguiar Andressa Simões AS   Barrientos Anna Carlotta Mott ACM   Sucupira Carolina C   De Paulis Milena M   Sáfadi Marco Aurélio Palazzi MAP   Silva Daniella Gregorio Bonfim Prado DGBP   Sodré Janaina Joice Martins JJM   Soledade Mariana Pereira MP   Matos Samantha Faria SF   Ferreira Sabrina Rodrigues SR   Pinez Célia Miranda Nunez CMN   Buonafine Carolina Palamin CP   Pieroni Leticia Nery Ferreira LNF   Malta Fernanda Mello FM   Santana Rubia Anita Ferraz RAF   Souza Eloisa Corrêa EC   Fock Ricardo Ambrosio RA   Pinho João Renato Rebelo JRR   Ferreira Luís Carlos Souza LCS   Botosso Viviane Fongaro VF   Durigon Edison Luiz EL   Oliveira Danielle Bruna Leal DBL  

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 20200807 3


In March 2020, WHO declared a pandemic state due to SARS-CoV-2 having spread. TaqMan-based real-time RT-qPCR is currently the gold standard for COVID-19 diagnosis. However, it is a high-cost assay, inaccessible for the majority of laboratories around the world, making it difficult to diagnose on a large scale. The objective of this study was to standardize lower cost molecular methods for SARS-CoV-2 identification. E gene primers previously determined for TaqMan assays by Colman et al. (2020) we  ...[more]

Similar Datasets

| S-EPMC4841946 | biostudies-literature
| S-EPMC3720699 | biostudies-literature
| S-EPMC3157457 | biostudies-literature
| S-EPMC3271430 | biostudies-literature
| S-EPMC4125142 | biostudies-literature
| S-EPMC8493944 | biostudies-literature
| S-EPMC8245607 | biostudies-literature
| S-EPMC5622608 | biostudies-literature
| S-EPMC9019801 | biostudies-literature
| S-EPMC6932758 | biostudies-literature